LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Forecast for Spinal Implant Market Looking Bright
Spine

Forecast for Spinal Implant Market Looking Bright

March 10, 2017 1 min read Premium comments

Advertisement

Forecast for Spinal Implant Market Looking Bright
Source: Wikimedia Commons and WebSized
Secondary

A recent “Spinal Implants and Devices Market Report” published by Allied Market Research forecasts a bright future for suppliers. They expect that the global market for spinal implants and devices will reach $13,384 million by 2022 which translates into an expected Compound Annual Growth Rate (CAGR) of 4.6% from 2016 to 2022. The market reached $9,741 million in 2015 with spinal fusion devices holding almost three-fifths of the total market share.

According to a press release, a rise in incidence of spinal disorders in an aging population and a shift to minimally invasive spine surgery as well as improvements in bone grafting products are all contributing factors in the expected growth. The use of spinal fusion implants, in particular, is expected to grow due to advancements like hook, rod and screw systems. Reimbursement and regulatory issues, however, may have a negative impact on market growth.

Some of the key findings of the report include:

  • Fusion implants segment is expected to grow at CAGR of 3.4% between 2016 and 2022.
  • Non-fusion/motion preservation segment and dynamic stabilization devices segment are both forecasted to grow at a CAGR of 10.9% during the same period.
  • Growth is expected to be the highest in the Asia-Pacific market with an expected CAGR of 5.7%.

Companies profiled in the report include Alphatec Holdings, Inc., B. Braun Melsungen AG, DePuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Read the full summary of the report here.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy